Can cardiac-resynchronization therapy reduce mortality in patients suffering from advanced chronic heart failure?
Cleland
John G F
JG
Academic Cardiology Unit, University of Hull, Castle Hill Hospital, Castle Road, Cottingham, Kingston upon Hull, HU16 5JQ, UK. J.G.Cleland@hull.ac.uk
Ghosh
Justin
J
Freemantle
Nick
N
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use*; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use*; D002304:Cardiac Pacing, Artificial; D004232:Diuretics / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D004554:Electric Countershock; D005500:Follow-Up Studies; D006333:Heart Failure / Q000401:mortality* / Q000503:physiopathology / Q000628:therapy*; D006760:Hospitalization / Q000706:statistics & numerical data / Q000639:trends; D006801:Humans; D013318:Stroke Volume / Q000502:physiology; D015996:Survival Rate; D013997:Time Factors; D016896:Treatment Outcome
D000319:Adrenergic beta-Antagonists; D000806:Angiotensin-Converting Enzyme Inhibitors; D004232:Diuretics